logo
Select company
Select metric
2.35Price to Book
VS
Market
44
Sector
50
Industry
49
History
8
$ 18.81Close
$ 7.38 - $ 61.57 52-Week Range
Ticker Information

Ticker

TNXP

Company Name

TONIX PHARMACEUTICALS HOLDING CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TONIX PHARMACEUTICALS HOLDING CORP - Price to Book Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNXP - P/B Historical data
DateShareholders EquityMarket CapitalizationPrice to Book
6/30/2025$ 168M$ 394.2M2.35
3/31/2025$ 180.4M$ 140.56M0.78
12/31/2024$ 139.56M$ 132.11M0.95
9/30/2024$ 74.21M$ 27.1M0.37
6/30/2024$ 42.1M$ 9.84M0.23
3/31/2024$ 108.14M$ 16.35M0.15
12/31/2023$ 105.53M$ 16.04M0.15
9/30/2023$ 120.83M$ 11.21M0.09
6/30/2023$ 140.46M$ 17.4M0.12
3/31/2023$ 165.43M$ 32.89M0.2
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TONIX PHARMACEUTICALS HOLDING CORP's latest trailing twelve months (TTM) P/B stands at 1.33.
  • Over the past 5 years, TONIX PHARMACEUTICALS HOLDING CORP's average P/B has been 0.88.
  • The median P/B for TONIX PHARMACEUTICALS HOLDING CORP during this period was 0.37
  • TONIX PHARMACEUTICALS HOLDING CORP reached its highest P/B over the past 5 years at 4.84.
  • The lowest P/B recorded by TONIX PHARMACEUTICALS HOLDING CORP in the same timeframe 0.09

TONIX PHARMACEUTICALS HOLDING CORP's P/B vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/B Benchmarks
CompanyP/B
PRTA : PROTHENA CORP PUBLIC LTD CO 1.15CAPR : CAPRICOR THERAPEUTICS INC 3.4LCTX : LINEAGE CELL THERAPEUTICS INC 4.77RLAY : RELAY THERAPEUTICS INC 0.9ABSI : ABSCI CORP 2.56PRME : PRIME MEDICINE INC 8.14TVRD : TVARDI THERAPEUTICS INC 6.78OCGN : OCUGEN INC 95.77FATE : FATE THERAPEUTICS INC 0.41SRZN : SURROZEN INC 1.74

Definition of Price to Book

[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
Market Cap / Equity
(=) P/B
P/B for TONIX PHARMACEUTICALS HOLDING CORP is calculated as follows: Market Cap [ $ 83.12M ] / Equity [ $ 62.57M ]
(=) P/B [ 1.33 ]

TNXP - Price to Book, Last 5 years

0.09

Minimum

Sep 30, 2023

4.84

Maximum

Dec 31, 2020

0.88

Average

0.37

Median

P/B Benchmark Analysis

The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
filtered constituents3.36K
min0
max8.04
average2.29
median1.63
std1.81